Pakistan Journal of Medical Sciences. 2013; 29 (2): 610-613
en Inglés
| IMEMR
| ID: emr-193648
ABSTRACT
Background and Objective:
Prostate cancer is the second leading cause of death in men. The localized disease often responds to conventional therapies like androgen ablation via castration and/or administration of chemical inhibitors but advanced disease resistant to any curative therapies is still challenge for investigators. There are increasing efforts to enhance the possibility of finding positive and sensitive immune markers for diagnosing and treating prostate cancer. The aim of this study was to investigate the expression patterns of AMACR and iNOS in prostate adenocarcinomas with different histopathologic grade
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Idioma:
Inglés
Revista:
Pak. J. Med. Sci.
Año:
2013
Similares
MEDLINE
...
LILACS
LIS